Patient information
Jobs
Blog
Organization
About Profil
Driving innovation in diabetes
Meet us at conferences
Locations
News
People
Board of Shareholders
Holding Management
Scientists
Career
Job profiles
Open positions
Your Application
Training as clinical pharmacologist
Training as study nurse
Research Focus
Diabetes treatment
Glucose lowering medication
Alternative route insulins
Insulin analogues
Diabetes complications
Incretin hormones
Medical technology
Insulin pump
Artificial pancreas
Glucose meters
Continuous glucose monitoring
Obesity treatment
Obesity
Impaired glucose tolerance
MASLD/MASH
Cardiometabolic research
Clinical Trial Services
Clinical development
Bioequivalence / biosimilar
Pharmacodynamics
Pharmacokinetics
Bridging studies
Safety and tolerability
Methods
Glucose clamp
Bodpod / body composition
Pancreatic clamp
Stable isotopes / metabolic fluxes
Adipose tissue and muscle biopsy
Transient elastography
Flow-mediated dilation
Retinal laser scanner
Skin laser Doppler
Standardized food intake / Nutrition
Exercise / energy expenditure
Other methods
Further services
Patient recruitment
GMP certified pharmacy
Data management, statistics and medical writing
Regulatory handling
Clinical development consulting
Knowledge Center
Scientific content
Publications
Online Seminars
Blog
Conference Posters
Diabetes Knowledge
Diabetes types
Diabetes prevention
Stem cells
Trial stages
What defines a specialized CRO for obesity trials?
What Profil’s expansion to the US means for pharma and biotechs
What Sponsors Should Look for in an Early-Phase Metabolic CRO
Leave a comment
Subscribe to Email Updates
Our most popular Posts
Posts by Topic
Clinical Trials in Diabetes
(127)
About Profil
(70)
Clinical Trial Methods
(68)
The Science behind Diabetes
(64)
Treating Diabetes
(62)
Diabetes Technology
(41)
Clinical trials in Obesity
(12)
Events
(4)
CRO selection
(3)
Regulatory Affairs
(2)
see all
You might also like this post
"What are glucose clamps and why do we need them?"
